Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

30.49

+0.44 (1.46%)

At close: May 29, 2026, 4:00 PM EDT

30.85

+0.36 (1.17%)

After-hours: May 29, 2026, 7:25 PM EDT

Rigel Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	299.77	294.28	179.28	116.88	120.24	149.24
Revenue Growth (YoY)	47.61%	64.15%	53.38%	-2.79%	-19.43%	37.39%
Cost of Revenue	19.82	19.62	18.65	7.11	1.75	1.08
Gross Profit	279.95	274.66	160.63	109.77	118.49	148.15
Selling, General & Admin	118.84	115.9	113.06	105.74	112.45	91.89
Research & Development	36.54	33.3	23.38	24.52	60.27	65.24
Other Operating Expenses	-	-	-	-	1.32	3.52
Total Operating Expenses	155.37	149.2	136.44	130.26	174.04	160.65
Operating Income	124.58	125.47	24.19	-20.49	-55.55	-12.5
Interest Income	4.3	3.68	2.09	2.27	0.68	0.05
Interest Expense	-6.9	-7.32	-7.92	-6.87	-3.71	-4.86
Total Non-Operating Income (Expense)	-2.61	-3.64	-5.83	-4.6	-3.02	-4.81
Pretax Income	121.97	121.83	18.37	-25.09	-58.57	-17.31
Provision for Income Taxes	-242.26	-245.2	0.88	-	-	0.61
Net Income	364.23	367.02	17.49	-25.09	-58.57	-17.91
Net Income to Common	364.23	367.02	17.49	-25.09	-58.57	-17.91
Net Income Growth	879.70%	1999.08%	-	-	-	-
Shares Outstanding (Basic)	18	18	18	17	17	17
Shares Outstanding (Diluted)	19	19	18	17	17	17
Shares Change (YoY)	7.63%	6.52%	1.64%	2.07%	-0.00%	1.03%
EPS (Basic)	20.07	20.40	0.99	-1.44	-3.44	-1.10
EPS (Diluted)	18.72	19.48	0.99	-1.44	-3.44	-1.10
EPS Growth	804.35%	1867.68%	-	-	-	-
Shares Outstanding	18.41	18.31	17.71	17.48	17.34	17.16
Free Cash Flow	79.29	75.66	31.44	-5.74	-74.21	5.25
Free Cash Flow Growth	4.80%	140.67%	-	-	-	-
Free Cash Flow Per Share	4.13	4.02	1.78	-0.33	-4.35	0.31
Gross Margin	93.39%	93.33%	89.60%	93.92%	98.55%	99.27%
Operating Margin	41.56%	42.63%	13.49%	-17.53%	-46.20%	-8.37%
Profit Margin	121.50%	124.72%	9.75%	-21.47%	-48.71%	-12.00%
FCF Margin	26.45%	25.71%	17.53%	-4.91%	-61.72%	3.52%
EBITDA	126.99	127.88	26.42	-19.25	-54.55	-11.33
EBITDA Margin	42.36%	43.46%	14.74%	-16.47%	-45.37%	-7.59%
EBIT	124.58	125.47	24.19	-20.49	-55.55	-12.5
EBIT Margin	41.56%	42.63%	13.49%	-17.53%	-46.20%	-8.37%
Effective Tax Rate	-198.62%	-201.27%	4.80%	0.00%	0.00%	-3.50%

SEC Filings: 10-K · 10-Q